StockWatch
·
Pharmaceuticals
Board Meeting28 Jul 2026, 08:11 pm

Sanofi Consumer Healthcare India Board Approves Q2 2026 Unaudited Results

AI Summary

Sanofi Consumer Healthcare India Ltd announced that its Board of Directors, in a meeting held on July 28, 2026, has approved the unaudited financial results for the quarter and half-year ended June 30, 2026. The company has submitted these results along with the Limited Review Report from statutory auditors, Price Waterhouse & Co Chartered Accountants LLP, as per SEBI Listing Regulations. The results will be published in newspapers and made available on the company's investor website. The board meeting commenced at 4:00 p.m. and concluded at 6:00 p.m.

Key Highlights

  • Board approved unaudited financial results for Q2 and H1 2026.
  • Results submitted as per SEBI Listing Regulations.
  • Limited Review Report from auditors included.
  • Financials to be published in newspapers and on company website.